The results proved that METTL5 mRNA in HCC specimens was up-regulated in terms of age from 21 to 40, N1, stage 4, grade 4, Asian race, TP53 mutation, and male patients (Fig. 5). Here, METTL5 is linked to hepatocellular carcinoma.